Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (2010 - 2025)

Ironwood Pharmaceuticals has disclosed Cash from Investing Activities across 16 years of filings, most recently posting $1000.0 for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at $1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$34000.0 (up 76.06% YoY), and the FY2025 annual result was -$34000.0, up 76.06% from the prior year.
• Cash from Investing Activities came in at $1000.0 for Q4 2025 at Ironwood Pharmaceuticals, up from -$2000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $27000.0 in Q4 2022 to a low of -$999.5 million in Q2 2023.
• The 5-year median for Cash from Investing Activities is -$44500.0 (2024), against an average of -$64.2 million.
• Across the five-year window, Cash from Investing Activities jumped 121.09% in 2022 and slumped 1135686.36% in 2023, its largest moves.
• Ironwood Pharmaceuticals' Cash from Investing Activities stood at -$128000.0 in 2021, then surged by 121.09% to $27000.0 in 2022, then sank by 15611.11% to -$4.2 million in 2023, then soared by 99.62% to -$16000.0 in 2024, then soared by 106.25% to $1000.0 in 2025.
• The last three Cash from Investing Activities figures came in at $1000.0 (Q4 2025), -$2000.0 (Q3 2025), and -$2000.0 (Q2 2025), per Business Quant data.